Pier Luigi Ferrarini

Cannabinoid CB2/CB1 Selectivity. Receptor Modeling and Automated Docking Analysis

Tiziano Tuccinardi, Pier Luigi Ferrarini, Clementina Manera et al. · Journal of Medicinal Chemistry · 2006 · 92 citations

Drug Target, Cannabinoid Pharmacology, Molecular Pharmacology +16

New 1,8-naphthyridine and quinoline derivatives as CB2 selective agonists

Clementina Manera, Maria Grazia Cascio, Veronica Benetti et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 71 citations · Full text

Molecular Pharmacology, Functional Selectivity, Medicine +6

Design, Synthesis, and Biological Evaluation of New 1,8-Naphthyridin-4(1<i>H</i>)-on-3-carboxamide and Quinolin-4(1<i>H</i>)-on-3-carboxamide Derivatives as CB₂Selective Agonists

Clementina Manera, Veronica Benetti, M. Paola Castelli et al. · Journal of Medicinal Chemistry · 2006 · 70 citations · Full text

Stereochemistry of the Additions of Acids to Stilbene and Styrene Oxides¹

Giancarlo Berti, F. Bottari, Pier Luigi Ferrarini et al. · The Journal of Organic Chemistry · 1965 · 69 citations

Chemical Engineering, Chemical Measurement, Engineering +13

Synthesis of 1,8-naphthyridine derivatives: Potential antihypertensive agents — Part VII

Pier Luigi Ferrarini, Claudio Mori, Muwaffag Badawneh et al. · European Journal of Medicinal Chemistry · 1998 · 54 citations

Medicinal Chemistry, Derivative (Chemistry), Derivatives +10